Current situation in the studies of gastrointestinal dynamic promoting drugs

World Chinese Journal of Digestology

Volumn 9, Issue 12, 2001, Pages 1439-1444

  Zhu, J Z ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

1 (2,3 DIHYDRO 1 METHYL 2 OXO 5 PHENYL 1H 1,4 BENZODIAZEPIN 3 YL) 3 (3 METHYLPHENYL)UREA; 1 [2 [[[5 (PIPERIDINOMETHYL) 2 FURANYL]METHYL]AMINO]ETHYL] 2 IMIDAZOLIDINYLIDENEPROPANEDINITRILE FUMARATE; 8,9 ANHYDRO N ETHYLNORERYTHROMYCIN A 6,9 HEMIACETAL; 8,9 ANHYDRO N ISOPROPYLNORERYTHROMYCIN A 6,9 HEMIACETAL; CHOLECYSTOKININ RECEPTOR BLOCKING AGENT; CISAPRIDE; DOMPERIDONE; DOPAMINE RECEPTOR BLOCKING AGENT; EM 536; ERYTHROMYCIN; FEDOTOZINE; HALOPERIDOL; INTESTINE CONTRACTION STIMULATING AGENT; LEUPRORELIN; LORGLUMIDE; LOXIGLUMIDE; MACROLIDE; METOCLOPRAMIDE; OCTREOTIDE; OPIATE AGONIST; PROSTAGLANDIN E1 DERIVATIVE; PRUCALOPRIDE; RENZAPRIDE; SEROTONIN 4 AGONIST; SOMATOSTATIN DERIVATIVE; UNCLASSIFIED DRUG; ZACOPRIDE;

CONSTIPATION; GASTROINTESTINAL MOTILITY; HUMAN; IRRITABLE COLON; REVIEW; STOMACH PARESIS;

EID: 0035686704     PISSN: 10093079     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (118)

1. The epidemiology of functional gastrointestinal disorders in North America
2. U. S. householder survey of functional gastrointestinal disorders
3. Evolving concepts in gastrointestinal motility
4. Clinical pharmacology forum: Motility agents and the gastrointestinal tract
5. Prokinetic agents
6. Improved nutrition after the detection and treatment of occult gastroparesis in dialysis patients
7. A double-blind multicenter comparison of domperidone and metoclopramide in the treatment of diabetic patients with symptoms of gastroparesis
8. Domperidone: A peripherally acting dopamine2-receptor antagonist
9. Meta-antisecretory and gastrokinetic compounds in functional dyspepsia
10. Efficacy of cisapride and domperidone in functional dyspepsia: A meta-analysis
11. Domperidone in the management of symptoms of diabetic gastropnresis: Efficacy, tolerability and quality of life outcomes in a multicenter controlled trial
12. Effect of domperidone on the health related quality of life of patients with symptoms of diabetic gastroparesis
13. Domperidone and hyperprolactinemia
14. Pharmacological charactorization of a neuronal receptor for 5-HT in guinea pig ileum with properties similar to 5-HT4 receptor
15. Effect of cisapride on gallbladder emptying and plasma CCK in normal and vagotomized human subjects
16. The influence of cisapride on the realease of some neurotransmitters in enteric myoplexus of guinea-pig
17. Survey of primary care physicians' approach to gasteoesophageal reflux disease in elderly patients
18. Cisapride decreases gastroesophageal reflux in preterm infants
19. Functional dyspepsia, insights on mechanisms and management strategies
20. Cisapride provides symptomatic relief in functional dyspepsia associated with gastricmyoelectrical abnormality
21. Comparative effects of levosulpiride and cisapride on gastric empting and symptoms in patients with functional dyspepsia and gastroparesis
22. Cisapride reduces neonatal postoperative ileus: Randomised placebo controlled trial
23. Intestinal pseudo-obstruction duo to neurofibromatosis responding to cisapride
24. Symptom atic improvement with one-year cisapride treatment in neuropathic chronic intestinal dysmotility
25. The symptomatic effect of cisapride in patients with irritable bowel syndrome and constipation
26. Cisapride for the treatment of constipation in children: A double-blind study
27. Cisapride for the treatment of contipation in children
28. Eeffect of cisapride on intestinal baoterial overgrowth and baoterial translocation in cirrhosis
29. Effect of oral cisapride on gallbladder emptying during fasting and postprandial states
30. Proarrhythmia associated with cisapride in children
31. A mechanism for the proarrhythmic effects of cisapride: High affinity blockade of the human cardiac potassium channel HERG
32. Blockage of the HERG human cardiac K + channel by the gastrointestinal prokinetic agent cisapride
33. Cisapride associated with QTc prolongation in very low birth weight preterm infants
34. Effect of different prokinetic agents and a novel enterokinetic agent on postoperative ileus in rats
35. Effect of a novel prokinetic drug, R093877, on gastrointestinal transit in healthy volunteers
36. Selective stimulation of colonic transit by the benzofuran 5HT4 agonist, prucalopride, in healthy humans
37. Effect of motilin and Erythromycin on calcium-activated potassium channels in rabbit colonic myocytes
38. Gastrokinetic effects of erythromycin: Myogenic and neurogenic mechanisms of action in rabbit stomach
39. Stimulatory mechanism of EM523-Induced contractions in postprandial stomach of conscious dogs
40. Gastrointestinal manifestations of progressive systemic sclerosis
41. Diabetic gastropathy: Gastric neuromuscular dysfunction in diabetes mellitus: A review of symptom, pathophysiology, and treatment
42. Prokinetics in patients with gastroparesis: A systematic analysis
43. Gastrointestinal features of scleroderma
44. Effect of octreotide and erythromycin on idiopathic and scleroderma associated intestinal peseudoobstruction
45. Antroduodenal motor effects of intravenous erythromycin in children with abnormalities of gastrointestinal motility
46. Treatment of cyclic vomiting in childhood with erythromycin
47. EM574, an erythromycin derivative, improves delayed gastric emptying of semi-solid meal in conscious dogs
48. Eradication of Helicobacter pylori vrestores the inhibitory effect of cholecystokinin on gastric motility in duodenal ulcer patients
49. Control of gestric emptying in the pig: Influence of cholecystokinin, somatostatin and prokinetic agents
50. Mediators and pharmacology of visceral sensitivity: From basic to clinical investigations
51. CCK-A receptors modulate gastric sensory and motor responses to gastric distention and duodenal lipid
52. Management of irritable bowel syndrome: Novel approaches to the pharmacology of gut motility
53. Role of opioid ligands in the irritable bowel syndrome
54. New development in the treatment of irritable bowel syndrome
55. Misoprostol in the treatment of chronic refractory constipation: Results of a long -term open label trial
56. Misoprostol therapeutics revisited
57. Octreotide treatment of chronic intestinal pseudoobstruction secondary to connective tissue disease
58. Effects of KW-5092 on antroduedenal coordination and gastric emptying in guinea-pigs
59. KW-5092, a novel gastrokinetic ageat, facilitates luminal serotonin release from the guinea pig colon
60. 5-HT3 antagonists in postoperative nausea and vomiting
61. Effect of atropine on the enhancing action of fructus Aurantii Immaturus on the myoelectric activity of small intestinal in dogs
62. Experimantal study for effect of some Chinese herbal on gastrointestinal motility
63. Effect of Saussura coppa on gastric function
64. A screening study of the kinetogenic effects of 15 chinese herbal medicines on the gastrointestinal tract in rats
65. Motilin changes and its significance in the kinetogenic effects of pericarpium arecae
66. Kinetogenic effects of pericarpium arecae on SP and VIP changes in gestrointestinal tract
67. The mechanical study of amomum villosum for its gastric motility promotion effect
68. Effect of Dan Shen on isolated gastric muscle strips in rats